Added to YB: 2023-12-24
Pitch date: 2023-12-24
IOBT [bullish]
IO Biotech, Inc.
-48.56%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform.
Market Cap
$54.5M
Pitch Price
$1.57
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.46
P/E
-0.62
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
IO BIOTECH INC IOBT
A summary for this pitch has not been created yet.
Read full article (0 min)